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T
wo symposia at the American Di-
abetes Association (ADA) 70th Sci-
entiﬁc Sessions, held on 25–29 June
2010, in Orlando, Florida, addressed as-
pects of the food industry’sa p p r o a c h
to satisfying the desire for sweets. One
examined noncaloric/nonnutritive sweet-
eners and the other fructose, and a num-
ber of research presentations addressed





Control Council, “an international non-
proﬁt association representing the low-
calorie food and beverage industry” (1),
discussed new noncaloric/nonnutritive
sweetener products available for consum-
ers. The Calorie Control National Con-
sumer Survey in 2007 showed that nearly
200 million individuals in the U.S., ;85%
of the population, use such sweeteners; of
thosewhodonot,38%donotlikethetaste
and only 8–11% do not use them because
of health concerns. The products’ major
uses are in soft drinks and sugar substi-
tutes, and almost one-half of those using
these products report daily use, increasing
from 40% in 2000.
Acceptable daily intakes of the cur-
rently available such sweeteners, acesul-
fame potassium, aspartame, neotame,
saccharin, steviua, and sucralose, are 15,
50, 18, 12, and 5 mg/kg body wt/day,
respectively. These are the maximal
amounts considered safe for daily con-
sumption over an individual’sl i f e t i m e ,
based on animal toxicology testing,
with a 100-fold safety factor (2,3). Such
intake would require an average adult,
using aspartame as an example, to con-
sume twenty 12-oz diet soft drinks, or
97 packets of sweetener, daily. Actual
consumption levels for the 50th, 90th,
and 95th percentiles of aspartame are es-
timated as being at most 4.8, 10.4, and
13.3 mg/kg body wt/day (4). Similar esti-
mates apply to the other available sweet-
eners, suggesting that even individuals
using large amounts of these products
do not consume levels exceeding safety
margins. Further, individuals using non-
nutritive sweeteners tend, Hubrich stated,
to have higher intake of fruits and vegeta-
blesand lower intake offat and added sug-
ars so have evidence of a healthier diet.
Similar studies have been carried out in in-
dividualswithdiabetes;thosedrinkingdiet
soda have lower consumption of high-fat
dairy products, processed meat, and re-
ﬁned sugar (5).
Stevia is a new nonnutritive sweet-
ener representing a family of glycosides,
in particular rebaudioside A. Used with
bulking agents, this is available in prod-
ucts such as PureVia, Stevia in the Raw,
and Sun Crystals in packets and in
granulated form and in Splenda, a product
now available in combination with ﬁber.
Advantame, a sweetener being developed,
made from aspartame in combination
with vanillin, is 20,000 times sweeter
than sucrose. Cyclamate, an older prod-
uct, is ;30 times sweeter than sucrose,
but blending of sweeteners may have syn-
ergistic effects, and various combinations
using this agent are now being developed.
Cyclamate was banned in the 1960s after
an animal study suggested carcinogenic-
ity, but a Food and Drug Administration
(FDA) ruling in 1984 concluded that ac-
tual evidence is lacking that amounts
used in man are carcinogenic. Other com-
bination products include aspartame/
saccharin, aspartame/acesulfame K, and
sucralose/acesulfame K.
Alan M. Rulis, Exponent ScientiﬁcC o n -
sulting, Inc. (Washington, DC), discussed
the development and implementation of
legislative and regulatory policy, explain-
inghowsafetyofnonnutritivesweeteners
is determined (6). He was at the FDA for
30yearsand from 1995–2004wasDirec-
tor of the FDA’sO f ﬁce of Food Additive
Safety. Rulis reviewed the history of ap-
proval of saccharin, developed in 1879
by Remsen and Fahlberg. Harvey Wiley,
an early pioneer of food chemistry, food
toxicology, and food safety, was the ﬁrst
commissioner of the FDA and thought
saccharin to be unsafe, presaging the
subsequent political battles over sweet-
eners in his disagreement with President
Theodore Roosevelt about this. In 1958,
it was put on the generally regarded as
safe(GRAS)list,in1977theFDAproposed
a ban on the product, the ban was then
overridden by Congress, and in 2000 the
warning label on saccharin was removed.
Rulis explained that the FDA requires as
a standard of safety “reasonable certainty
of no harm” but speciﬁcally does not
require “proof beyond any possible
doubt that no harm will result under
any conceivable circumstance” (7).
“Harm to health” assessment requires
estimation of probable consumer expo-
sure in the context of relevant animal
toxicological safety information. An ap-
propriate safety factor is considered
one-tenth that causing harm in animal
studies, and to account for differences
in human characteristics, this is divided
again by one-tenth, leading to one-
hundredth of the minimum amount
toxic in animals as the amount (on a
weight-adjusted basis) considered safe
in humans. Against this must be bal-
anced by the Delaney Clause require-
ment that “no additive shall be deemed
tobesafeifitisfoundtoinducecancerin
man or animal ...after tests which are
appropriate for the evaluation of the
safety of food additives” [Amendment
t ot h eF D & CA c tS e c4 0 9 ( c )( 3 )( A ) ] .
(It is interesting to note that direct test-
ing to rule out human toxicity, then,
does not seem to actually be required, a
major distinction from the approach
taken with pharmaceutical products.)
Rulisdiscussedacesulfame-K,discov-
ered accidentally in 1967 by Karl Clauss
of Hoechst. Its proposed use in bever-
ages led to concern that there would be
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PERSPECTIVES ON THE NEWShigh potential intake levels and raised
questions related to product stability. The
product does hydrolyze to a small extent
at low pH and under long-term storage
conditions at high temperatures. Because a
hydrolysis breakdown product leads to
hypertrophyoffollicularcellsofthethyroid,
the question of carcinogenicity was raised.
Many other thyroid carcinogens were then
studied to ascertain potential toxic dosages,
with these doses extrapolated to propose
what might be the maximal risk of the
acesulfame K metabolite. With this calcu-
lation, which, surprisingly, did not itself
actually require speciﬁc studies with the
chemical in question, risk was determined
to be extremely low and the product was
approved. Sucralose was originally devel-
oped by McNeil, ﬁl e di nM a y1 9 8 7 ,w i t h
ﬁnalsafetyjudgmentandapprovalin1997–
1999. A rodent study showed what was
felt to be excessive weight loss, but mul-
tiple additional studies failed to show
evidence of this. Another question was
raisedastowhethersucraloseisassociated
with increased hemoglobin glycation, but
additional studies showed no such effect,
leading to approval. Again, it is not clear
that extensive human studies were carried
out. Another path was taken for the stevia
glycoside rebaudioside A, approval of
whichwasbasedontheGRASexemption,
with application beginning in 2008 and
FDA response 8 months later. The prod-
uct was determined to be a “food addi-
tive,” for which there was no evidence of
lack of safety, based on the presence of
data in the public domain accepted by
qualiﬁed scientists. Of course, lack of ev-
idenceofharmisnot thesameasevidence
of lack of harm! This logic may not be
considered applicable to the development
of food standards by the FDA.
France Bellisle (Quebec, Canada) re-
viewed potential mechanisms of the ef-
fects of nonnutritive sweeteners on food
intake and appetite. Appetite, she said,
m a yb ec o n s i d e r e dab r o a dc o n c e p t
associated with the acceptance of foods
and the willingness to ingest them, af-
fected by palatability, with sweetness a
strong appetite stimulus. Substances that
confer sweetness, either sugars or intense
sweeteners, might then stimulate food
intake under circumstances either of
hungerorofeatinginresponsetohedonic
stimuli. The enjoyment of sweet taste
may be considered a reﬂex, as has been
shown by studies of facial expressions
of infants given a drop of sweet, sour,
or bitter liquid (8). Another concept is
that of satiety, the state of fullness or
repletion after food intake inhibiting
further consumption until hunger re-
turns. It varies according to total energy
loadanddensityandwithnutrientcontent,
with protein possibly giving rise to greater
satiety than carbohydrate, which in turn
may be more satiating than fat. Other fac-
tors include food volume and sensory and
cognitive factors enhancing or decreasing
the intensity or duration of satiety.
Bellisle discussed the question of
whether nonnutritive sweeteners may
“uncouple sweetness and calories” (9),
a notion that has led to the concept
that dissociation between sweet taste
and calories may disrupt hormonal and
neurobehavioral pathways regulating
hunger. This implies that nonnutritive
sweeteners may not be as satiating as
sugar or could actually cause hunger
(10), tricking the body into overeating,
or may overstimulate taste receptors,
creating sweet taste addiction. Such
sweeteners could then actually have
adverse rather than beneﬁcial effect.
Bellislepointedoutthattheeffectofnon-
nutritive sweeteners on caloric intake
depends greatly on the food, with 100 g
of sugar- versus intense sweetener–
containing soda having 40 vs. 2 kcal, fruit
drink56vs.11kcal,andlow-fatyogurt75
vs. 44 kcal but chocolate 513 vs. 510 kcal.
She reviewed a study comparing nonnu-
tritive with nutritive sweeteners to assess
whether the consumer compensates for
the reduction in energy consumption,
using a preload study design where,
after a test substance is ingested, the sub-
sequent hunger and desire to eat were
measured. After ingestion of a plain yo-
gurt-like product or after ingestion of the
same product with aspartame (300 kcal
each), appetite was somewhat reduced
with either sucrose or maltodextrins
(700 kcal each), suggesting that the devel-
opmentofsatietyisaneffectofthecalories
consumed rather than of the sweetness of
the ingested food (11).
Ap a r t i c u l a ri s s u ei st h a ts u g a r -
containing drinks may have “low satiety
power,” therefore adding an important
energy load without eliciting adequate di-
etary compensation (12), although there
isanargumentagainstthisnotion.Bellisle
showed studies in which energy from
drinks added to calories without trigger-
ing compensatory decreases in solid food
intake, implying that removing sugar
fromdrinkswouldnotbelikelytoincrease
food intake. She reviewed the Su.Vi.Max
study, in which she was an investigator,
following 1,200 French adults and
comparing regular consumers with non-
consumers of nonnutritive sweeteners.
Theformerwereheavierbutingestedfewer
calories and, in particular, less sugar, sug-
gesting that the nonnutritive sweeteners
did not enhance appetite overall or for
sweet products (13). This ﬁnding was
corroborated by analysis of individuals
consuming diet sodas in the U.S. in the
Multiethnic Study of Atherosclerosis
(MESA). These individuals were more
likely to exercise and less likely to smoke
cigarettes, although their body weight
and waist circumference were greater
than that of individuals consuming
sugar-sweetened beverages (5). Similarly,
diet soda was not a marker for “unhealthy
lifestyle” but was, rather, associated with
more ingestion of whole grains, fruit,
low-fatdairyproducts,desserts,andcoffee
and less of processed meat, reﬁned grains,
and sugar-sweetened soda. A study of gro-
cery purchase patterns of 1,574 individu-
als found that those purchasing diet soda
made better nutrition choices (14). Bellisle
discussed a meta-analysis of 16 random-
ized controlled trials in which replacing
sugars by nonnutritive sweeteners was
associated with a 10% reduction in daily
energyintake,withanaverage0.2kg/week
greater weight loss and with less weight
regain after weight loss. Although there
is an animal model showing that over-
eating follows exposure to saccharin-
and sucrose-containing beverages (15),
Bellisle commented that there is no evi-
dence that human consumption of diet
beverages increases either appetite or en-
ergyintake(16)and,indeed,thatfrequent
users of nonnutritive sweeteners showed
the same level of appetite for sweet-tasting
substances as those not drinking such
products (17). A study of individuals
who had maintained .10% weight loss
for .5 years showed that they consumed
less dietary fat and more artiﬁcially sweet-
ened beverages and were more physically
active (18). Functional magnetic imaging
studies do show, Bellisle stated, that al-
though both sucrose and the nonnutritive
sweetener sucralose activate primary taste
pathways,only sucroseactivates domami-
nergic midbrain areas, suggesting that the
brain is capable of distinguishing the two
and that only the former might effectively
reduce food intake. On balance, however,
Bellisle concluded that that the use of
nonnutritive sweeteners is beneﬁcial
and allows substantial difference in en-
ergy intake. She pointed out that there is
a beneﬁcial, presumably cognitive, effect
and that consumers of these sweeteners
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erages with an overall pattern of healthy
food choices.
FRUCTOSE—In a symposium on di-
etary sweeteners containing fructose,
Julie A. Miller-Jones (St. Paul, MN) dis-
cussed misconceptions about fructose
and high-fructose corn syrup (HFCS),
reviewing the history and chemistry and
some commonly held myths about the
product. She pointed out that “fructose
has been in the news,” with some well-
respected investigators arguing that it is
relatedtometabolicsyndromeandabnor-
mal lipid panels while others have argued
that “there is insufﬁcient evidence to ...
restrict high fructose corn syrup ...[but
rather that] advice to limit consump-
tion of all added caloric sweeteners, in-
cluding fructose, is warranted” (19).
Both fructose, a ketose, and glucose, an
aldose, are reducing sugars, which com-
bine to form sucrose. Fructose is found in
fruit, honey, and table sugar. Sources of
dietary fructose include agave, the richest
natural source of fructose, with 85% of
carbohydrate in this form; honey, with
approximately 50%; and fruit juices.
HFCSismadefromacid-oramylase-treated
corn starch and contains 42–55% fruc-
tose; Miller-Jones commented, “It’s higher
than corn syrup ...but it’s not high.” In
contrast, apple and pear juice have .66%
fructose; asparagus, raspberries, spinach,
and watermelon have 56–65% fructose;
and most fruits and nuts have 42–55%
fructose. In most foods, fructose and glu-
cose are present in equal proportion, an
availability ratio that has changed little
over the past 40 years. HCFS is similar in
sweetness to sucrose, is fermentable by
yeast, has greater moisture retention and,
because of the reducing sugar aspect, in-
creases browning of foods but isless likely
to crystallize.
Over the period from 1970, accord-
ingtodisappearancedata,availableadded
sugar calories have increased 19% but the
per capita increase in total calories has
been 24%. It does appear that we have to
some extent substituted fructose for su-
crose. The greatest increase, however, is
in added fats and in cereal and grain
products. The most recent National
HealthandNutritionExaminationSurvey
(NHANES) of 15,189 individuals, sug-
gests an increase in daily sugar intake of
83.1 g equivalents from 1994–1996 lev-
els. Approximately 76% of the U.S. pop-
ulation consumes ,20% of their energy
as sugar, while 13% consume .25% of
their calories as added sugar, particularly
teenagers and young adults, coming
mainly from sodas and, to a lesser extent,
sweetened grain products, leading Miller-
Jones to state, “The message that we want
to drive home is, ‘Eat more fruit.’”
Fructose is associated in epidemio-
logic studies with greater weight, tri-
glyceride, blood pressure, and insulin
resistance levels and in animal and hu-
man feeding studies with small dense
LDL cholesterol, nonalcoholic fatty liver
disease, and greater levels of protein
glycation. Fructose intake, based on
disappearance data studies, has corre-
lated over the past ﬁve decades with
increasing obesity prevalence (20).
Studies speciﬁcally examining HFCS
show its level to correlate strongly with
theprevalenceofobesityandoverweight
(21) and, similarly, use of sweetened
beverages correlatesw i t hb o d yw e i g h t
(22). “The tragedy,” Miller-Jones stated,
“isthatyoucan[consume.800kcalina
soft drink] and not think you’ve con-
sumedcalories....It’sthebiggulpthat’s
the problem.” Although an animal
model has shown greater weight gain
with HFCS (23), she suggested that
theseﬁndingsofthestudyweremethod-
ologically problematic. The one effect of
HFCS that does appear reproducible, in
her assessment, is its association with
elevation in triglyceride levels (24),
with other effects simply related to in-
creased consumption of calories. At
very highlevels of ingestion, comprising
25% of energy intake, fructose- rather
than glucose-sweetened beverages are
associated with increased levels of intra-
abdominal fat, increased lipids, and
decreased insulin sensitivity (25). The
combination of 60% fat and fructose
caused obesity, high triglyceride, and
glucose intolerance in another animal
model (26). The increasingly recognized
effect of fructose on uric acid levels (27)
was not discussed. Another question
Miller-Jones raised is whether rodents
are an imprecise model for effect of fruc-
tose, given that de novo lipogenesis
constitutes 60–70% of fat synthesis in
rodents—far more than the 10–20% in
humans.
Extremely high fructose intake levels
are uncommon, Miller-Jones stated, “in
nature.” She reviewed a meta-analysis
of clinical studies showing no effect of
,3 month studies of moderate or high
fructose intake either in normal or in
diabetic individuals on body weight,
going on to cite a recent review, which
stated,“Ingestionoffructoseinanormal,
dietary manner ...does not cause bio-
logically relevant changes in triglyceride
orbodyweight[even]whenconsumedat
levels approaching 95th percentile esti-
matesofintake”(28).Theissuemaythen
be the adverse effect of high-level con-
sumption of any sugar. In a study of 34
men fed either 25% sucrose or 25%
HFCS, both diets increased triglyceride
levels similarly (29), although another
study comparing 25% fructose with glu-
cose feeding showed the former to in-
crease lipids and intra-abdominal fat
(30).Perhapsbecausefruitsarerelatively
high in fructose, epidemiological studies
have actually shown an inverse associa-
tion of fructose intake with diabetes
prevalence (31). Miller-Jones concluded
that excess calories, rather than HFCS,
are what cause adverse effects (32). Her
thesis, then, is that sucrose and HFCS
are virtually the same, other than in
cost, and that “large amounts of all sug-
ars should be avoided.... A calorie is
a calorie whether it comes from glu-
cose, fructose, or a combination of
both.” She described as “our real prob-
lem” t h ed i l e m m ad e s c r i b e di nar e v i e w
by David Jenkins, “Too much sugar,
too much carbohydrate, or just too
much?” (33).
Michele M. Doucette (Denver, CO)
further discussed the notion “that all nat-
urally occurring sweeteners are equally
caloric...[although] fructose consumed
in isolation and in high amounts can
cause abnormal metabolic proﬁles.” She
suggested that sucrose is likely to have
similar effects and reviewed the relation-
shipbetweentotaladdedsugarsandobe-
sity and diabetes. “The obesity epidemic
is not abating,” she stated, with obesity
overtaking overweight in population
prevalence beginning in 2006. Obesity
isofcourseassociatedwithtype2diabetes,
with a comparison of NHANES 1976–
1980 and 2005–2006 showing particular
increase in obesity among individuals
with diabetes in the more recent survey.
Whatdrivesobesityisenergybalance,
related to genetics, ethnicity, food con-
sumption patterns, and activity patterns,
which have not increased in keeping with
the increase in energy intake. “There’s
food abundance, there’sv e n d i n gm a -
chines...they’reeatingoutmore...por-
tion sizes have increased.” What is
needed, then, Doucette said, is a “socio-
ecologic framework for preventing obe-
sity” addressing food intake and physical
activity, with appropriate understanding
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well as individual factors in changing
both elements of this balance.
She asked,“Howdoes thisallconnect
in with added sugars?” Naturally occur-
ring sugarsintrinsicinwholefruit,grains,
vegetables, and milk products may be
compared with extrinsic sugars added
during food processing or consumption.
Loss-adjusted food availability data from
1980–2006 showed an increase in sugar
consumption from 106 to 130 g/day.
There are a variety of dietary guidelines,
with most agreeing that ;10% of total
calories consumed should be as sugars.
“We’re eating a lot of the foods that
are more energy dense and less nutrient
dense ...much less of the healthy foods,”
Doucette said. Too many soft drinks,
sugar sweets, and sweetened grains and
too few fruit drinks and milk products
are consumed. The mean daily amount
of sugar added to the diet is ;50 g/day.
One difﬁculty is that the nutrition facts
panel in food labels does not directly give
added sugar content. Common sugars in
foods include sucrose, fructose, lactose,
maltose, glucose, dextrose, corn syrups,
honey, molasses, and fruit juice concen-
trates; interestingly, corn syrup is not
considered an added sugar; useful Web
sites with information about sugars in
food are labelwatch.com, fatsecret.com/
calories-nutrition, and thedailyplate.com.
Doucette suggested that the “source of
added sugar is not the primary concern.
Most important is the amount of total cal-
ories.” She discussed the newly released
2010dietaryguidelines,which suggestnu-
trient-dense foods, vegetables, fruits, and
high-ﬁber whole grains, with low levels of
solid fats, added sugars, and sodium, sug-
gesting that diet be integrated in practical
terms that promote personal choices.
FOOD AND NUTRITIONAL
SUPPLEMENT PRESENTATIONS
AT THE ADA MEETING—Kitabchi
et al. (abstract 108-LB) compared effects
of 30% protein, 40% CHO, and 30% fat
vs. 15% protein, 55% CHO, and 30% fat
500 kcal hypocaloric diets in 11 obese
nondiabetic premenopausal women over
3 months; the two diets led to a com-
parable fall in weight, blood pressure,
C-reactiveprotein,tumornecrosisfactor-a,
and interleukin-6, but the former led
to greater improvement in glucose toler-
ance and two oxidative stress markers,
dichloroﬂuorescein and malondialde-
hyde. Darakhshan et al. (abstract 1772)
treated 13 obese individuals with 4-week
hypocaloric high protein vs. conventional
diets, also ﬁnding no signiﬁcant difference
in weight loss or total fat, but with a sig-
niﬁcant decrease in adipocyte diameter
and plasma leptin with the former; they
suggested the strategy of alternating be-
tweenthetwodietswith controlledwash-
out intervals for obesity management.
Pasupuleti et al. (abstract 110-LB) ad-
ministered a dietary supplement containing
“soy and whey ... peptides ... minerals,
antioxidants, vitamins, cinnamon extracts,
insulinotropic amino acids/peptides, and
soluble and insoluble ﬁber and then for-
mulated with milk protein and organic soy
milk” versus placebo to 59 type 2 diabetic
individualsfor12weeks,ﬁndingA1Creduc-
tions of 1.6 vs. 0.7%, respectively, and fast-
ing glucose reductions of 39 vs. 5 mg/dL.
Malik et al. (abstract 1766) reported that
participants in the Nurses’ Health Survey
with higher dairy intake during adoles-
cence had reduced risk of diabetes; Rosal
et al. (abstract 1767), however, reported
that dairy beverages constituted 9% of
caloric intake among adult Latino dia-
betic patients with A1C .7.5%, whereas
juices, fruit drinks, and regular sodas ac-
counted for 7% of total calories, together
offering readily addressed areas for re-
duction in energy intake.
Chacko et al. (abstract 109-LB) ad-
ministered 500 mg magnesium daily (as
the citrate) versus placebo in a 4-week
crossover trial of 14 overweight nondia-
betic healthy individuals, showing a sig-
niﬁcant decrease in fasting C-peptide
with downregulation of complement
C1q,proplateletbasicprotein,and tumor
necrosis factor–related protein 9 genes
andupregulationofthetransientreceptor
potential channel genes TRPM6 and
TRPM7, compatible with magnesium’s
known favorable metabolic effects. Ali
et al. (abstract 1763) randomized 59 in-
dividuals with impaired fasting glucose,
impaired glucose tolerance, or metabolic
syndrome to chromium picolinate 500 or
1,000 mg daily or placebo daily, showing
no effect on insulin sensitivity, fasting or
2-hglucose,weight,bloodpressure,A1C,
lipids, or urine albumin levels.
Dondoi and Mogos (abstract 1774)
treated 42 type 2 diabetic individuals
receiving 1,500 mg metformin daily
with 2 g n-3 fatty acids daily, as well as
1gvitaminCdailytopreventoxidationof
the former; homeostasis model insulin
resistance decreased 13%, and those with
hypertriglyceridemia at baseline de-
creased triglyceride levels from 425 to
183 mg/dL. Costacou et al. (abstract
1757) followed ;600 type 1 diabetic in-
dividuals for 18 years, ﬁnding a 48%
lower likelihood of coronary disease
among men in the highest versus lower
three quartiles of n-3 fatty acid dietary in-
take; there was no effect in women. Cor-
rection for HDL and LDL cholesterol and
triglycerides, however, made the former
association nonsigniﬁcant. Dragomir
et al. (abstract 193) allocated 290 type 2
diabetic individuals to diets with or
withoutsupplementalﬁshoilcapsulescon-
taining 1 g eicosapentanoic acid, 1 g doco-
sahexanoic acid, and 0.1 g a-tocopherol
acetate for 12 months, showing the sup-
plemented group to have signiﬁcantly
lower carotid intima-medial thickness
progression. Utzschneider et al. (abstract
197) randomized 19 nondiabetic indi-
viduals to high- versus low-fat isocaloric
diets for 4 weeks, ﬁnding greater reduc-
tion in liver fat by magnetic resonance
spectroscopy with the latter in associa-
tionwithreductionintotalandHDLand
LDL cholesterol and increase in plasma
triglycerides.
Kim et al. (abstract 1762) analyzed
dietary habit questionnairesin2,865type
2 diabetic patients from the Korean
National Diabetes Program and found
lower BMI to be associated with eating 3
meals versus 1–2 meals daily (despite
fewer reported calories with the latter),
with regularly timed meal schedules,
and with slower rather than more rapid
eatingpatterns. Stullet al.(abstract 1769)
reported greater improvement in insulin
sensitivity (hyperinsulinemic-euglycemic
clamp) of 32 obese, nondiabetic, and
insulin-resistant subjects with two daily
servings of a 16-oz. liquid shake con-
taining 22.5 g freeze-dried blueberry
powder than with an equicaloric placebo
shake.
Kirwan et al. (abstract 196) studied
22 older obese adults during a 12-week
exercise training period with high- versus
low-glycemic index foods and found
similar improvement in weight, insulin
sensitivity, and visceral fat but reduced
postload insulin,glucagon-likepeptide1,
and glucose-dependent insulinotropic
polypeptide levels only in the latter
group. Silva et al. (abstract 1768) ana-
lyzed 3-day weighed-diet records of 175
type 2diabeticindividualsand found that
the metabolic syndrome (deﬁned by the
presenceofanythreeofﬁvefactors:central
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glucose $100 mg/dL) was associated
with the glycemic index of the overall
diet, with the breakfast glycemic index
appearing to account for all of the differ-
ence between those with and those with-
out the syndrome.
Pittas et al. (abstract 198) compared
608 women with newly diagnosed type 2
diabetes and 559 control subjects in the
Nurses’ Health Study and found 25-OH
vitaminDlevelsinthehighestversuslow-
est quartile to be associated with 48%
lower likelihood of diabetes. Jarvandi
et al. (abstract 1758) did not ﬁnd an as-
sociation of dietary vitamin D with blood
pressure but found that during the
months with low sun exposure, individ-
uals who did or did not use vitamin sup-
plementation had a mean systolic blood
pressure of 134.5 vs. 139 mmHg, respec-
tively, adjustedforage,sex,BMI,physical
activity, ethnicity, smoking, alcohol,
number of antihypertensive medications,
and total energy and nutrients addressed
in DASH diet recommendations.
Ketterer et al. (abstract 1764), noting
the presence of insulin receptors in sev-
eral brain areas including the olfactory
bulb, found that a hyperinsulinemic-
euglycemic clamp reduced olefactory
function, which suggests a potential reg-
ulatory step for hunger and satiety and
leads to the question of what if any
changes occur in these parameters in
diabetes and with insulin resistance.
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